Literature DB >> 1675177

Transglutaminase differentiation during maturation of human blood monocytes to macrophages.

B Seiving1, K Ohlsson, C Linder, P Stenberg.   

Abstract

There are divergent reports in the literature on the character of transglutaminases in monocytes and macrophages. The aim of the present study was to further elucidate the characteristics and functions of various transglutaminases in monocytes and macrophages. Peripheral human blood monocytes were plated and cultured for up to a month and examined for transglutaminase. Freshly prepared monocytes contained cellular Factor XIII only. Successively during culturing, the monocytes matured into macrophages. Cellular Factor XIII correspondingly disappeared and tissue transglutaminase increased during the same time. After approximately 2 weeks in culture only tissue transglutaminase was detected and this remained for the rest of the culturing period. The tissue transglutaminase content was induced by addition of 2 mumols/l retinoic acid. Addition of retinoic acid was not critical for transglutaminase differentiation. Transglutaminase could be associated with phagocytosis of 125I-trypsin-alpha 2-macroglobulin complexes. The phagocytotic capacity of monocytes was approximately 1/4 compared to macrophages cultured for 14 days. Phagocytosis was measured as cellular complex degradation to monoiodo-tyrosine, released to the culture medium. The monocytes and macrophages were incubated at 4 degrees C and 37 degrees C, with and without addition of the transglutaminase inhibitor monodansylthiacadaverine. Addition of 100 mumols/l monodansylthia-cadaverine caused approximately 2/3 inhibition of phagocytosis. These results suggest that transglutaminase differentiates from cellular Factor XIII into tissue type transglutaminase during maturation of monocytes into macrophages and that the differentiation is associated with transglutaminase-dependent phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675177     DOI: 10.1111/j.1600-0609.1991.tb01537.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

Review 1.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

2.  Factor XIIIa-positive dendrocytes and proliferative activity of cutaneous cancers.

Authors:  C Piérard-Franchimont; J E Arrese; A F Nikkels; W al-Saleh; P Delvenne; G E Piérard
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

3.  Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer.

Authors:  Kapil Mehta; Amy Han
Journal:  Cancers (Basel)       Date:  2011-02-25       Impact factor: 6.639

4.  Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.

Authors:  Nathaly Espitia Pinzon; Esther Stroo; Bert A 't Hart; John G J M Bol; Benjamin Drukarch; Jan Bauer; Anne-Marie van Dam
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

Review 5.  Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?

Authors:  Navina L Chrobok; Claudia Sestito; Micha M M Wilhelmus; Benjamin Drukarch; Anne-Marie van Dam
Journal:  Amino Acids       Date:  2016-09-22       Impact factor: 3.520

6.  Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions.

Authors:  Navina L Chrobok; John G J M Bol; Micha M M Wilhelmus; Benjamin Drukarch; Anne-Marie van Dam
Journal:  J Neuropathol Exp Neurol       Date:  2019-06-01       Impact factor: 3.685

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.